1-20 of 59 results for subject:Iofendylate
Librarians' tools
- Search time
- 0.237 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:Iofendylate
- We searched for
- subject_t:Iofendylate OR subject_t:Myodil OR subject_ses:94357
Type
House
Session
Year
Department
Member
More
Primary member
More
Answering member
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health what estimate he has made of the number of people who have physical problems as a result of being injected with Myodil; and if he will make a statement.
[143627]
To ask the Secretary of State for Health what estimate he has made of the number of people who have physical problems as a result of being injected with Myodil; and if he will make a statement.
[143627]
We have made no estimate. The issues surrounding the use of Myodil in myelography and patients who received Myodil and who continue to experience physical problems are complex. Medical opinion indicates that the symptoms which some patients experience may be due to the original condition, degenerative back disease, or surgery or other medical procedure. Few cases of adhesive arachnoiditis, which is the condition associated with the use of Myodil, have been reported from the millions of myelograms that have been performed and the incidence of adhesive arachnoiditis due solely to the presence of Myodil or other contrast agent is not known.
To ask the Secretary of State for Health if he will hold discussions with the World Health Organisation and the European Union on the continued use of Myodil overseas following its withdrawal from UK markets.
To ask the Secretary of State for Health if he will hold discussions with the World Health Organisation and the European Union on the continued use of Myodil overseas following its withdrawal from UK markets.
Inquiries Bill (HL). Second reading debate. Agreed to on question. Programme motion on Committal, Standing Committee, Report, Third Reading and any other proceedings agreed to on question (formal). Queens recommendation signified. Money resolution agreed to on question (formal). Relevant documents: HC 51 2004/05, Cm 6481, HC 606 i-vii 2003/04, HC 51 i-iii 2004/05 and HC 388 2004/05.
Inquiries Bill (HL). Second reading debate. Agreed to on question. Programme motion on Committal, Standing Committee, Report, Third Reading and any other proceedings agreed to on question (formal). Queens recommendation signified. Money resolution agreed to on question (formal). Relevant documents: HC 51 2004/05, Cm 6481, HC 606 i-vii 2003/04, HC...
To ask the Secretary of State for Health, what guidance was available in the (a) 1970s and (b) 1980s in respect of routine recording of myodil injections on medical records; and if he will make a statement.
To ask the Secretary of State for Health, what guidance was available in the (a) 1970s and (b) 1980s in respect of routine recording of myodil injections on medical records; and if he will make a statement.
To ask the Secretary of State for Health, what research has been carried out into the side effects of myodil. - Inc figures.
To ask the Secretary of State for Health, what research has been carried out into the side effects of myodil. - Inc figures.
To ask the Secretary of State for Health, how many people have suffered injury as a result of having been injected with myodil. - Inc fact that information requested is not available.
To ask the Secretary of State for Health, how many people have suffered injury as a result of having been injected with myodil. - Inc fact that information requested is not available.
To ask the Secretary of State for Health, how many patients were given myelography with myodil between 1971 and 1987; and of those how many subsequently developed arachnoiditis.
To ask the Secretary of State for Health, how many patients were given myelography with myodil between 1971 and 1987; and of those how many subsequently developed arachnoiditis.
To ask the Secretary of State for Health, on what date the drug Myodil was granted a product licence of right under the terms of the Medicines Act 1968. - Inc figures.
To ask the Secretary of State for Health, on what date the drug Myodil was granted a product licence of right under the terms of the Medicines Act 1968. - Inc figures.
To ask the Secretary of State for Health, how many yellow card scheme reports since 1989 have been received by the Medicines Control Agency regarding adverse reaction to metrizamide/myodil; and if he will make a statement. - Inc figures.
To ask the Secretary of State for Health, how many yellow card scheme reports since 1989 have been received by the Medicines Control Agency regarding adverse reaction to metrizamide/myodil; and if he will make a statement. - Inc figures.
To ask the Secretary of State for Health, how much iophendylate was purchased by the National Health Service in 1998-99. - No iophendylate (Myodil) was purchased by the National Health Service in 1998-99.
To ask the Secretary of State for Health, how much iophendylate was purchased by the National Health Service in 1998-99. - No iophendylate (Myodil) was purchased by the National Health Service in 1998-99.
To ask the Secretary of State for Health, if he will introduce a no-fault compensation scheme for those who have suffered from arachnoiditis as a result of medical treatment.
To ask the Secretary of State for Health, if he will introduce a no-fault compensation scheme for those who have suffered from arachnoiditis as a result of medical treatment.
To ask the Secretary of State for Health, if he will institute a full public inquiry on the links between Myodil and arachnoiditis.
To ask the Secretary of State for Health, if he will institute a full public inquiry on the links between Myodil and arachnoiditis.
To ask the Secretary of State for Scotland, if he will list each of the further and higher education colleges participating in the University of the Highlands and Islands Project; when they signed contracts to participate in the project; and when these contracts (a) expired and (b) were renewed; and...
To ask the Secretary of State for Scotland, if he will list each of the further and higher education colleges participating in the University of the Highlands and Islands Project; when they signed contracts to participate in the project; and when these contracts (a) expired and (b) were renewed; and...
To ask the Secretary of State for Health, if he will investigate the alleged link between adhesive arachnoiditis and the use of Myodil.
To ask the Secretary of State for Health, if he will investigate the alleged link between adhesive arachnoiditis and the use of Myodil.
To ask the Secretary of State for Health if he will establish a public inquiry into the use of Myodil in myelography and into the associated risks of adhesive arachnoiditis.
To ask the Secretary of State for Health if he will establish a public inquiry into the use of Myodil in myelography and into the associated risks of adhesive arachnoiditis.
To ask the Secretary of State for Health, what assessment his Department has made of the risk of myelography causing arachnoiditis.
To ask the Secretary of State for Health, what assessment his Department has made of the risk of myelography causing arachnoiditis.
Wednesday adjournment debate on adhesive arachnoiditis.
Wednesday adjournment debate on adhesive arachnoiditis.
To ask the Secretary of State for Health, for what reasons Glaxo was granted a licence for Myodil; and what assessment he has made of overseas evidence that the drug is unsafe.
To ask the Secretary of State for Health, for what reasons Glaxo was granted a licence for Myodil; and what assessment he has made of overseas evidence that the drug is unsafe.
To ask the Secretary of State for Health, for what reasons his Department has decided not to proscribe the use of Myodil in myelography.
To ask the Secretary of State for Health, for what reasons his Department has decided not to proscribe the use of Myodil in myelography.
What representations his Department has received from, and what assistance it has given to (a) the Myodil Action Group and (b) the Arachnoiditis Trust since 1987; and what research his Dept has (a) commissioned and (b) evaluated into seeking a cure for arachnoiditis.
What representations his Department has received from, and what assistance it has given to (a) the Myodil Action Group and (b) the Arachnoiditis Trust since 1987; and what research his Dept has (a) commissioned and (b) evaluated into seeking a cure for arachnoiditis.